TPI India (500421)

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Piotroski F-Score 7/9 suggests improving operational and financial fundamentals
• Latest quarter net profit of ₹1 Cr on sales of ₹8 Cr implies a solid 12.5% net margin
• Reported ROCE of 99.12% indicates efficient capital utilization, if the figure is reliable
• Profit growth of 200% shows strong earnings momentum, though from a low base
• Price near 52-week high of ₹22.45 indicates market recognition of the turnaround

Concerns

• P/E of 88.89 is very expensive, offering less than 1.2% earnings yield
• ROE is negative at -5.89%, reflecting poor shareholder returns or an eroded equity base
• Sales growth of only 2.44% means the underlying business is nearly stagnant
• No dividend and unavailable data on debt/equity, book value, and promoter holding reduce transparency

AI Analysis

Looking at TPI India, I'm reminded that the first rule is not to lose money. This is a tiny packaging company with a market cap of just ₹91 Cr and a trailing P/E of 88.89 — that means the market is paying an enormous price for every rupee of current earnings. The latest quarter shows sales of ₹8 Cr and net profit of ₹1 Cr, so there's a pulse, but one strong quarter does not make a wonderful business. Sales growth is only 2.44%, so the top line is nearly flat; the 200% profit growth is from a very low base, and cannot be extrapolated with confidence. ROE is deeply negative at -5.89%, which tells me shareholder returns have been poor, even though ROCE is reported at 99.12%. That contradiction makes me suspicious — perhaps capital employed is thin, or there are extraordinary items. The Piotroski score of 7/9 is encouraging; it suggests improving fundamentals. But at this price, I need a margin of safety. There is no dividend and no meaningful data on debt, book value, or promoter holding, so I'm flying partially blind. Valuation is my main worry: even a small hiccup could crush the share price. In Buffett's words, it's far better to buy a wonderful business at a fair price, but this doesn't yet look wonderful. It looks like a possible turnaround being offered at a very hopeful price. I would wait for more quarters of earnings, lower valuation, or a clearer understanding of the balance sheet before committing capital. For a patient investor, missing a trade is far cheaper than losing capital.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer